Conversely to CTLA-4 and PD-1, TIGIT was associated to NK-cell exhaustion in a mouse model of colon cancer and TIGIT blockade was capable of reverting the condition allowing NK cells to trigger an anti-tumor immune response. The gene discussed is TIGIT; the disease is colonic neoplasm.